The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after

…, HJ Asbun, MG Besselink, K Conlon, M Del Chiaro… - Surgery, 2017 - Elsevier
Background In 2005, the International Study Group of Pancreatic Fistula developed a
definition and grading of postoperative pancreatic fistula that has been accepted universally. …

Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines

NCM Van Huijgevoort, M Del Chiaro… - Nature reviews …, 2019 - nature.com
Pancreatic cystic neoplasms (PCN) are a heterogeneous group of pancreatic cysts that
include intraductal papillary mucinous neoplasms, mucinous cystic neoplasms, serous cystic …

The Miami international evidence-based guidelines on minimally invasive pancreas resection

…, U Boggi, MP Callery, M Del Chiaro… - Annals of …, 2020 - journals.lww.com
Objective: The aim of this study was to develop and externally validate the first evidence-based
guidelines on minimally invasive pancreas resection (MIPR) before and during the …

European experts consensus statement on cystic tumours of the pancreas

M Del Chiaro, C Verbeke, R Salvia, G Klöppel… - Digestive and Liver …, 2013 - Elsevier
Cystic lesions of the pancreas are increasingly recognized. While some lesions show benign
behaviour (serous cystic neoplasm), others have an unequivocal malignant potential (…

[HTML][HTML] Neoadjuvant treatment in pancreatic cancer

…, MH Al-Musawi, RD Schulick, M Del Chiaro - Frontiers in …, 2020 - frontiersin.org
Thanks to the development of modern chemotherapeutic regimens, survival after surgery for
pancreatic ductal adenocarcinoma (PDAC) has improved and pancreatologists worldwide …

[HTML][HTML] Pancreatectomy with arterial resection is superior to palliation in patients with borderline resectable or locally advanced pancreatic cancer

M Del Chiaro, E Rangelova, A Halimi, Z Ateeb… - Hpb, 2019 - Elsevier
Background Few studies have investigated the outcome of pancreatectomy associated with
artery resection (PAR). Methods Retrospective analysis of a cohort of operated borderline or …

Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer

…, IQ Molenaar, JW Wilmink, M Del Chiaro… - Nature Reviews …, 2024 - nature.com
Surgical resection combined with systemic chemotherapy is the cornerstone of treatment for
patients with localized pancreatic cancer. Upfront surgery is considered suboptimal in cases …

Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology

…, EG Chiorean, V Chung, B Czito, M Del Chiaro… - Journal of the National …, 2021 - jnccn.org
Pancreatic cancer is the fourth leading cause of cancer-related death among men and women
in the United States. A major challenge in treatment remains patients’ advanced disease …

Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) …

…, KA Overbeek, R Brand, S Syngal, M Del Chiaro… - Gut, 2020 - gut.bmj.com
Background and aim The International Cancer of the Pancreas Screening Consortium met
in 2018 to update its consensus recommendations for the management of individuals with …

MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity

E Giovannetti, N Funel, GJ Peters, M Del Chiaro… - Cancer research, 2010 - AACR
MicroRNA-21 (miR-21) was reported to be overexpressed and contributes to invasion and
gemcitabine resistance in pancreatic ductal adenocarcinoma (PDAC). The aim of this study …